These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 20171410)
1. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410 [TBL] [Abstract][Full Text] [Related]
2. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Cömez AT; Tufan HA; Kocabıyık O; Gencer B Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565 [TBL] [Abstract][Full Text] [Related]
3. A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes. Xiao Q; Hu Y; Chen F; Chen X J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):592-5. PubMed ID: 18846346 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropyl-guar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye. Maharana PK; Raghuwanshi S; Chauhan AK; Rai VG; Pattebahadur R Middle East Afr J Ophthalmol; 2017; 24(4):202-206. PubMed ID: 29422755 [TBL] [Abstract][Full Text] [Related]
5. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye. Markoulli M; Wong K; Jia T; Siddireddy JS; Briggs N; Tan J Cont Lens Anterior Eye; 2022 Dec; 45(6):101736. PubMed ID: 35835650 [TBL] [Abstract][Full Text] [Related]
6. Lubricant with gelling agent in treating dry eye in adult Chinese patients. Waduthantri S; Yong SS; Tan CH; Htoon HM; Tong L Optom Vis Sci; 2012 Nov; 89(11):1647-53. PubMed ID: 23069726 [TBL] [Abstract][Full Text] [Related]
7. Autologous serum eye drops for dry eye. Pan Q; Angelina A; Marrone M; Stark WJ; Akpek EK Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009327. PubMed ID: 28245347 [TBL] [Abstract][Full Text] [Related]
8. A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes. Kallarackal GU; Ansari EA; Amos N; Martin JC; Lane C; Camilleri JP Eye (Lond); 2002 Sep; 16(5):594-600. PubMed ID: 12194075 [TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye. Jacobi C; Kruse FE; Cursiefen C J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209 [TBL] [Abstract][Full Text] [Related]
10. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N; Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Carbomer-Based Lipid-Containing Artificial Tear Formulations in Patients With Dry Eye Syndrome. Chung SH; Lim SA; Tchach H Cornea; 2016 Feb; 35(2):181-6. PubMed ID: 26509769 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations. Wang IJ; Lin IC; Hou YC; Hu FR Eur J Ophthalmol; 2007; 17(2):151-9. PubMed ID: 17415686 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome. Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry Eye. Dienes L; Kiss HJ; Perényi K; Szepessy Z; Nagy ZZ; Barsi Á; Acosta MC; Gallar J; Kovács I PLoS One; 2015; 10(8):e0135629. PubMed ID: 26302222 [TBL] [Abstract][Full Text] [Related]
15. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients. Altiparmak UE; Acar DE; Ozer PA; Emec SD; Kasim R; Ustun H; Duman S Eye (Lond); 2010 Jun; 24(6):1044-50. PubMed ID: 19834507 [TBL] [Abstract][Full Text] [Related]
16. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes. Xiao W; Huang P Arq Bras Oftalmol; 2022; 87(2):0539. PubMed ID: 36169441 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time. Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481 [TBL] [Abstract][Full Text] [Related]
18. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Benelli U; Nardi M; Posarelli C; Albert TG Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684 [TBL] [Abstract][Full Text] [Related]
19. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Ozen S; Ozer MA; Akdemir MO Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439 [TBL] [Abstract][Full Text] [Related]
20. Short-term consumption of oral omega-3 and dry eye syndrome. Kangari H; Eftekhari MH; Sardari S; Hashemi H; Salamzadeh J; Ghassemi-Broumand M; Khabazkhoob M Ophthalmology; 2013 Nov; 120(11):2191-6. PubMed ID: 23642375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]